In addition, IGF1 upregulates the expression of the anti-apoptotic proteins Bcl-2, Bcl-XL, and survivin, thus promoting a drug-resistant tumor cell phenotype associated with metastatic hMM [46]. The gene discussed is IGF1; the disease is neoplasm.